TCON
Income statement / Annual
Last year (2023), TRACON Pharmaceuticals, Inc.'s total revenue was $12.05 M,
and the percentage change from the previous year is not available.
In 2023, TRACON Pharmaceuticals, Inc.'s net income was -$3.59 M.
See TRACON Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$12.05 M
|
$0.00
|
$346,000.00
|
$0.00
|
$0.00
|
$3.00 M
|
$8.76 M
|
$3.45 M
|
$7.90 M
|
$3.60 M
|
Cost of Revenue |
$12.28 M |
$16,000.00 |
$14,000.00 |
$12,000.00 |
$22,000.00 |
$30.46 M |
$19.36 M |
$15.24 M |
$20.43 M |
$4.85 M |
Gross Profit |
-$232,000.00 |
-$16,000.00 |
$332,000.00 |
-$12,000.00 |
-$22,000.00 |
-$27.46 M |
-$10.60 M |
-$11.80 M |
-$12.53 M |
-$1.26 M |
Gross Profit Ratio |
-0.02 |
0 |
0.96 |
0 |
0 |
-9.15 |
-1.21 |
-3.42 |
-1.58 |
-0.35 |
Research and Development
Expenses |
$12.28 M
|
$13.89 M
|
$11.15 M
|
$8.20 M
|
$14.53 M
|
$30.46 M
|
$19.36 M
|
$21.57 M
|
$25.68 M
|
$7.65 M
|
General & Administrative
Expenses |
$6.67 M
|
$14.01 M
|
$17.55 M
|
$8.03 M
|
$7.77 M
|
$7.28 M
|
$7.61 M
|
$7.86 M
|
$5.69 M
|
$2.13 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$6.67 M
|
$14.01 M
|
$17.55 M
|
$8.03 M
|
$7.77 M
|
$7.28 M
|
$7.61 M
|
$7.86 M
|
$5.69 M
|
$2.13 M
|
Other Expenses |
$0.00 |
-$1.24 M |
-$320,000.00 |
-$7,000.00 |
-$378,000.00 |
$12,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$18.93 M |
$27.89 M |
$28.69 M |
$16.22 M |
$22.30 M |
$37.74 M |
$26.97 M |
$29.43 M |
$31.37 M |
$9.78 M |
Cost And Expenses |
$18.94 M |
$27.89 M |
$28.69 M |
$16.22 M |
$22.30 M |
$37.74 M |
$26.97 M |
$29.43 M |
$31.37 M |
$9.78 M |
Interest Income |
$0.00 |
$994,000.00 |
$318,000.00 |
$545,000.00 |
$386,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$7.30 M |
$994,000.00 |
$318,000.00 |
$545,000.00 |
$386,000.00 |
$231,000.00 |
$886,000.00 |
$1.12 M |
$923,000.00 |
$667,000.00 |
Depreciation &
Amortization |
$14,000.00
|
$16,000.00
|
$14,000.00
|
$12,000.00
|
$22,000.00
|
$28,000.00
|
$48,000.00
|
$94,000.00
|
$51,000.00
|
$15,000.00
|
EBITDA |
-$6.88 M
|
-$27.89 M
|
-$28.33 M
|
-$16.22 M
|
-$22.27 M
|
-$34.71 M
|
-$18.17 M
|
-$25.80 M
|
-$23.42 M
|
-$6.16 M
|
EBITDA Ratio |
-0.57 |
0 |
-81.93 |
0 |
0 |
-11.58 |
-1.98 |
-7.23 |
-2.85 |
-1.54 |
Operating Income Ratio
|
-0.57
|
0
|
-81.93
|
0
|
0
|
-11.58
|
-2.08
|
-7.53
|
-2.97
|
-1.72
|
Total Other
Income/Expenses Net |
$3.31 M
|
-$1.24 M
|
-$320,000.00
|
-$552,000.00
|
-$378,000.00
|
-$219,000.00
|
-$893,000.00
|
-$1.03 M
|
-$943,000.00
|
-$630,000.00
|
Income Before Tax |
-$3.59 M |
-$29.14 M |
-$28.67 M |
-$16.78 M |
-$22.67 M |
-$34.96 M |
-$19.10 M |
-$27.01 M |
-$24.41 M |
-$6.81 M |
Income Before Tax Ratio
|
-0.3
|
0
|
-82.85
|
0
|
0
|
-11.65
|
-2.18
|
-7.83
|
-3.09
|
-1.89
|
Income Tax Expense |
$0.00 |
$177,000.00 |
$59,000.00 |
$551,000.00 |
-$16,000.00 |
$12,000.00 |
$845,000.00 |
$938,000.00 |
$892,000.00 |
$615,000.00 |
Net Income |
-$3.59 M |
-$29.31 M |
-$28.73 M |
-$17.33 M |
-$22.66 M |
-$34.96 M |
-$19.10 M |
-$27.01 M |
-$24.41 M |
-$6.81 M |
Net Income Ratio |
-0.3 |
0 |
-83.02 |
0 |
0 |
-11.65 |
-2.18 |
-7.83 |
-3.09 |
-1.89 |
EPS |
-2.2 |
-28.02 |
-33.3 |
-38.63 |
-149.35 |
-259.47 |
-227.33 |
-426.06 |
-439.2 |
-113.7 |
EPS Diluted |
-2.19 |
-28.02 |
-33.3 |
-38.57 |
-149.35 |
-259.47 |
-227.33 |
-426.06 |
-439.2 |
-113.7 |
Weighted Average Shares
Out |
$1.63 M
|
$1.05 M
|
$862,632.00
|
$448,529.00
|
$151,715.00
|
$134,731.00
|
$84,033.00
|
$63,390.00
|
$55,578.00
|
$59,887.00
|
Weighted Average Shares
Out Diluted |
$1.64 M
|
$1.05 M
|
$862,632.00
|
$449,207.00
|
$151,715.00
|
$134,731.00
|
$84,033.00
|
$63,390.00
|
$55,578.00
|
$59,887.00
|
Link |
|
|
|
|
|
|
|
|
|
|